Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

14.8K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
14.8K
T Cell Types and Functions01:24

T Cell Types and Functions

2.2K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.2K
Abnormal Proliferation02:23

Abnormal Proliferation

5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Bridging the gap in OA therapeutics: Bioengineered strategies to target osteoclast-chondrocyte crosstalk.

Bioengineering & translational medicine·2026
Same author

A Noachian hydrosphere component in the 4.1-Ga Martian meteorite Teghaza 001.

Science advances·2026
Same author

Dexmedetomidine may alleviate severe acute pancreatitis-associated lung injury by targeting the AIM2 inflammasome in endothelial cells.

BMC anesthesiology·2026
Same author

Determination of HU override for gold fiducial markers in proton therapy.

Journal of applied clinical medical physics·2026
Same author

A Rare Case of Lower Gastrointestinal Bleeding: Appendiceal Dieulafoy's Lesion.

Digestive diseases and sciences·2026
Same author

CELF family of RNA-binding proteins: roles in disease biology and potential for therapeutic intervention.

Cell communication and signaling : CCS·2026
Same journal

Anlotinib Combined with Programmed Death-1/Programmed Death-Ligand 1 Inhibitor 9 Hydrochloride Suppresses Colorectal Cancer Progression by Inducing Neovascularization and Reprogramming the Tumor Immune Microenvironment in MSS Murine Model.

ImmunoTargets and therapy·2026
Same journal

T Helper Cells and Cytokine Networks in the Immunopathogenesis of Multiple Sclerosis.

ImmunoTargets and therapy·2026
Same journal

Irinotecan Modulates Immune Checkpoints in Neuroblastoma.

ImmunoTargets and therapy·2026
Same journal

Unveiling a ceRNA Network Involving IL-8 and TNF-α in Active Generalized Vitiligo by Multi-Omics Integration.

ImmunoTargets and therapy·2026
Same journal

Myeloid Cell-Derived Thrombospondin-1 Mediates Anti-Metastatic Effects of Histamine Dihydrochloride in B16 Melanoma.

ImmunoTargets and therapy·2026
Same journal

The Immune Architecture of Eosinophilic Esophagitis: Mechanisms, Therapeutic Targets, and Precision Management.

ImmunoTargets and therapy·2026
查看所有相关文章

相关实验视频

Updated: Jan 17, 2026

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

9.1K

多发性骨髓瘤中的T细胞功能障碍

Linyu Cai1, Liping Zuo1, Guangqi Wang1

  • 1Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430022, People's Republic of China.

ImmunoTargets and therapy
|September 17, 2025
PubMed
概括
此摘要是机器生成的。

多发性骨髓瘤免疫疗法显示出希望,但面临来自骨髓免疫抑制环境的挑战. 本综述探讨了T细胞在免疫逃避中的作用,并提出了提高治疗疗效的策略.

关键词:
在CTL中,CTL是CTL.Th17 这是一个很好的方法.这就是Treg Treg.免疫系统的逃脱是免疫逃脱.免疫抑制细胞是免疫抑制细胞.多发性骨髓瘤是多发性骨髓瘤的一种.

更多相关视频

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
10:04

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

13.5K
Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

7.2K

相关实验视频

Last Updated: Jan 17, 2026

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

9.1K
Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
10:04

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

13.5K
Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

7.2K

科学领域:

  • 血液恶性瘤研究研究
  • 免疫疗法机制 免疫疗法机制
  • 癌症免疫学 癌症免疫学

背景情况:

  • 多发性骨髓瘤 (MM) 是一种血细胞恶性瘤,由于抗CD38抗体,CAR-T细胞和TCEs等免疫疗法改善了存活率.
  • 骨髓微环境带来了重大的免疫抑制挑战,限制了MM目前免疫疗法的有效性.
  • 了解免疫规避机制对于开发克服这些局限性并改善患者治疗结果的策略至关重要.

研究的目的:

  • 系统地审查涉及多发性骨髓瘤免疫规避的T细胞亚型.
  • 突出最近关于非传统T细胞和MM免疫反应中的代谢控制的研究.
  • 讨论针对MM进展中的免疫逃避机制的新型治疗策略.

主要方法:

  • 对T细胞亚型和多发性骨髓瘤中免疫逃避的最新研究进行系统性文献综述.
  • 对聚焦于骨髓微环境免疫抑制作用的研究进行分析.
  • 对非传统T细胞,代谢重编程和治疗干预措施的研究进行审查.

主要成果:

  • 鉴定出各种T细胞亚型,在MM微环境中促进免疫逃避.
  • 强调了在MM进展中免疫监测和抑制之间的不平衡.
  • 详细介绍了最近对影响免疫细胞功能和治疗点的代谢途径的详细发现.

结论:

  • 免疫抑制性骨髓微环境是有效的MM免疫疗法的关键障碍.
  • 针对T细胞功能障碍,代谢重编程和免疫逃避策略对于增强MM治疗至关重要.
  • 对非传统T细胞和代谢控制的进一步研究为多发性骨髓瘤的新疗法开发提供了有希望的途径.